Involvement of Nucleus Accumbens SERCA2b in Methamphetamine-induced Conditioned Place Preference

Overview

Journal Addict Biol

Specialty Psychiatry

Date 2024 Mar 15

PMID 38488467

Authors

Yujing Wang

Fan Duan

Junda Li

Xiangyu Li

Lingling Xia

Wei Zhao

Ze Wang

Xun Song

Juan Chen

Jingjing Wang

Yue Wang

Jing Zhang

Xiaochu Zhang

Dongliang Jiao

Affiliations

Soon will be listed here.

Abstract

Methamphetamine (METH) is a highly addictive psycho-stimulant that induces addictive behaviour by stimulating increased dopamine release in the nucleus accumbens (NAc). The sarco/endoplasmic reticulum calcium ion transport ATPases (SERCA or ATP2A) is a calcium ion (Ca2+) pump in the endoplasmic reticulum (ER) membrane. SERCA2b is a SERCA subtype mainly distributed in the central nervous system. This study used conditioned place preference (CPP), a translational drug reward model, to observe the effects of SERCA and SERCA2b on METH-CPP in mice. Result suggested that the activity of SERCA was significantly decreased in NAc after METH-CPP. Intraperitoneal SERCA agonist CDN1163 injection or bilateral CDN1163 microinjection in the NAc inhibited METH-CPP formation. SERCA2b overexpression by the Adeno-associated virus can reduce the DA release of NAc and inhibit METH-CPP formation. Although microinjection of SERCA inhibitor thapsigargin in the bilateral NAc did not significantly aggravate METH-CPP, interference with SERCA2b expression in NAc by adeno-associated virus increased DA release and promoted METH-CPP formation. METH reduced the SERCA ability to transport Ca2+ into the ER in SHSY5Y cells in vitro, which was reversed by CDN1163. This study revealed that METH dysregulates intracellular calcium balance by downregulating SERCA2b function, increasing DA release in NAc and inducing METH-CPP formation. Drugs that target SERCA2b may have the potential to treat METH addiction.

Citing Articles

Involvement of nucleus accumbens SERCA2b in methamphetamine-induced conditioned place preference.

Wang Y, Duan F, Li J, Li X, Xia L, Zhao W Addict Biol. 2024; 29(3):e13382.

PMID: 38488467 PMC: 11061847. DOI: 10.1111/adb.13382.

References

Thastrup O, Cullen P, Drobak B, Hanley M, Dawson A . Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase. Proc Natl Acad Sci U S A. 1990; 87(7):2466-70. PMC: 53710. DOI: 10.1073/pnas.87.7.2466. View

Salvador J, Berengena M, Sepulveda M, Mata A . Distribution of the intracellular Ca(2+)-ATPase isoform 2b in pig brain subcellular fractions and cross-reaction with a monoclonal antibody raised against the enzyme isoform. J Biochem. 2001; 129(4):621-6. DOI: 10.1093/oxfordjournals.jbchem.a002899. View

Voigt R, Mickiewicz A, Napier T . Repeated mirtazapine nullifies the maintenance of previously established methamphetamine-induced conditioned place preference in rats. Behav Brain Res. 2011; 225(1):91-6. PMC: 3170466. DOI: 10.1016/j.bbr.2011.07.009. View

Herrold A, Shen F, Graham M, Harper L, Specio S, Tedford C . Mirtazapine treatment after conditioning with methamphetamine alters subsequent expression of place preference. Drug Alcohol Depend. 2008; 99(1-3):231-9. DOI: 10.1016/j.drugalcdep.2008.08.005. View

Taylor C, Broad L . Pharmacological analysis of intracellular Ca2+ signalling: problems and pitfalls. Trends Pharmacol Sci. 1998; 19(9):370-5. DOI: 10.1016/s0165-6147(98)01243-7. View

Nguyen E, McCracken K, Liu Y, Pouw B, Matsumoto R . Involvement of sigma (sigma) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies. Neuropharmacology. 2005; 49(5):638-45. DOI: 10.1016/j.neuropharm.2005.04.016. View

Wei T, Li J, Wang Y, Zhao W, Duan F, Wang Y . p-Nrf2/HO-1 Pathway Involved in Methamphetamine-induced Executive Dysfunction through Endoplasmic Reticulum Stress and Apoptosis in the Dorsal Striatum. Neurotox Res. 2023; 41(5):446-458. DOI: 10.1007/s12640-023-00650-7. View

Ebner S, Roitman M, Potter D, Rachlin A, Chartoff E . Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens. Psychopharmacology (Berl). 2010; 210(2):241-52. PMC: 2894632. DOI: 10.1007/s00213-010-1836-5. View

Yang M, Kim S, Jung M, Shim J, Ryu N, Yook Y . Proteomic analysis of methamphetamine-induced reinforcement processes within the mesolimbic dopamine system. Addict Biol. 2008; 13(3-4):287-94. DOI: 10.1111/j.1369-1600.2007.00090.x. View

10.

Ureshino R, Erustes A, Bassani T, Wachilewski P, Guarache G, Nascimento A . The Interplay between Ca Signaling Pathways and Neurodegeneration. Int J Mol Sci. 2019; 20(23). PMC: 6928941. DOI: 10.3390/ijms20236004. View

11.

DeMarco A, Dalal R, Pai J, Aquilina S, Mullapudi U, Hammel C . Racemic gamma vinyl-GABA (R,S-GVG) blocks methamphetamine-triggered reinstatement of conditioned place preference. Synapse. 2008; 63(2):87-94. PMC: 5004629. DOI: 10.1002/syn.20582. View

12.

Sim M, Soga T, Pandy V, Wu Y, Parhar I, Mohamed Z . MicroRNA expression signature of methamphetamine use and addiction in the rat nucleus accumbens. Metab Brain Dis. 2017; 32(6):1767-1783. DOI: 10.1007/s11011-017-0061-x. View

13.

Jiao D, Liu Y, Long J, Du J, Ju Y, Zan G . Involvement of dorsal striatal α1-containing GABAA receptors in methamphetamine-associated rewarding memories. Neuroscience. 2016; 320:230-8. DOI: 10.1016/j.neuroscience.2016.02.001. View

14.

Chen X, Xing J, Jiang L, Qian W, Wang Y, Sun H . Involvement of calcium/calmodulin-dependent protein kinase II in methamphetamine-induced neural damage. J Appl Toxicol. 2016; 36(11):1460-7. DOI: 10.1002/jat.3301. View

15.

Britzolaki A, Cronin C, Flaherty P, Rufo R, Pitychoutis P . Chronic but not acute pharmacological activation of SERCA induces behavioral and neurochemical effects in male and female mice. Behav Brain Res. 2020; 399:112984. PMC: 7855138. DOI: 10.1016/j.bbr.2020.112984. View

16.

Siciliano C, Calipari E, Ferris M, Jones S . Biphasic mechanisms of amphetamine action at the dopamine terminal. J Neurosci. 2014; 34(16):5575-82. PMC: 3988413. DOI: 10.1523/JNEUROSCI.4050-13.2014. View

17.

Matsumoto R, Shaikh J, Wilson L, Vedam S, Coop A . Attenuation of methamphetamine-induced effects through the antagonism of sigma (sigma) receptors: Evidence from in vivo and in vitro studies. Eur Neuropsychopharmacol. 2008; 18(12):871-81. PMC: 2688716. DOI: 10.1016/j.euroneuro.2008.07.006. View

18.

Rose M, Grant J . Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions. Ann Clin Psychiatry. 2008; 20(3):145-55. DOI: 10.1080/10401230802177656. View

19.

Zhihao L, Jingyu N, Lan L, Michael S, Rui G, Xiyun B . SERCA2a: a key protein in the Ca cycle of the heart failure. Heart Fail Rev. 2019; 25(3):523-535. DOI: 10.1007/s10741-019-09873-3. View

20.

Chanaday N, Nosyreva E, Shin O, Zhang H, Aklan I, Atasoy D . Presynaptic store-operated Ca entry drives excitatory spontaneous neurotransmission and augments endoplasmic reticulum stress. Neuron. 2021; 109(8):1314-1332.e5. PMC: 8068669. DOI: 10.1016/j.neuron.2021.02.023. View